Provided by Tiger Trade Technology Pte. Ltd.

Sight Sciences, Inc.

8.47
-0.0900-1.05%
Post-market: 8.470.00000.00%16:15 EDT
Volume:233.48K
Turnover:1.99M
Market Cap:466.60M
PE:-15.22
High:8.64
Open:8.40
Low:8.35
Close:8.56
52wk High:9.71
52wk Low:3.19
Shares:55.09M
Float Shares:37.29M
Volume Ratio:0.53
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5564
EPS(LYR):-0.7369
ROE:-48.42%
ROA:-10.84%
PB:8.82
PE(LYR):-11.49

Loading ...

Sight Sciences Q2 Revenue USD 23.4 Million Vs. IBES Estimate USD 21.7 Million

Reuters
·
Aug 06

Sight Sciences Q2 EPS USD -0.08

THOMSON REUTERS
·
Aug 06

Sight Sciences Outlook FY REV $88 Million to $92 Million

THOMSON REUTERS
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), OrthoPediatrics (KIDS) and Sight Sciences (SGHT)

TIPRANKS
·
Aug 05

Sight Sciences announces FDA clearance of Omni Ultra Surgical System

TIPRANKS
·
Aug 05

Sight Sciences Receives FDA 510(k) Clearance of the Omni Ultra Surgical System

THOMSON REUTERS
·
Aug 05

Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System

GlobeNewswire
·
Aug 05

Sight Sciences, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Sight Sciences Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Sight Sciences to $7 From $11, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Sight Sciences to Report Q2 Financial Results After Market Close

Reuters
·
Jul 23

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

GlobeNewswire
·
Jul 23

Sight Sciences is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 08

Sight Sciences price target raised to $6 from $5.15 at Citi

TIPRANKS
·
Jul 08

Citi Keeps Their Hold Rating on Sight Sciences (SGHT)

TIPRANKS
·
Jul 08

Top Executives Quietly Unload Sight Sciences Shares in a Significant Insider Shake-Up

TIPRANKS
·
Jul 07

Insider Confidence Surges as Sight Sciences Director Makes Bold Stock Move

TIPRANKS
·
Jun 12

Sight Sciences director, 10% owner Staffan Encrantz buys 14,100 shares worth $68,793.90

Reuters
·
Jun 12

Sight Sciences Shareholders Reelect Directors, Ratify Auditor

TIPRANKS
·
Jun 06

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
May 29